# The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia

> **NCT00826111** · PHASE4 · COMPLETED · sponsor: **Steward St. Elizabeth's Medical Center of Boston, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Depression
- Anxiety
- Insomnia

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00826111
- **Lead sponsor:** Steward St. Elizabeth's Medical Center of Boston, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-01
- **Final completion:** 2011-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00826111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00826111, "The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00826111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*